首页> 美国卫生研究院文献>Cancer Biology Medicine >Why bortezomib cannot go with ‘green’?
【2h】

Why bortezomib cannot go with ‘green’?

机译:为什么硼替佐米不能与绿色搭配使用?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Eat more ‘green’ or eat ‘five a day’ is one of the most important healthy lifestyle behaviours in the 21 century. Aiming to fight cancer effectively, more than half patients use vitamins or herbs concurrently with conventional anticancer treatment. Flavonoids or polyphenols existing in vegetables, fruits and green tea are common plant pigments with antioxidant properties and considered acting as cancer preventing or anti-cancer agents. Recently it was found that some flavonoids and vitamin C in diet or supplements have antagonistic effect with the anti-cancer drug bortezomib. Bortezomib is a specific inhibitor for proteasome and is currently used for treatment of relapsed and refractory multiple myeloma. Despite its successful rates in treating multiple myeloma and other solid tumors, it is unable to kill leukemic cells in the blood. It was recently revealed that some flavonoids and vitamin C present in green leaves and green teas in the blood can neutralize bortezomib by directly interaction between two chemicals. Here we summarize why dietary flavonoids should be avoided in patients who take bortezomib as chemotherapeutic drug.
机译:多吃“绿色食品”或“一日五餐”是21世纪最重要的健康生活方式。为了有效对抗癌症,超过一半的患者在常规抗癌治疗的同时使用维生素或草药。蔬菜,水果和绿茶中存在的类黄酮或多酚是常见的植物色素,具有抗氧化特性,被认为是预防癌症或抗癌药。最近发现,饮食或补品中的某些类黄酮和维生素C与抗癌药硼替佐米具有拮抗作用。硼替佐米是蛋白酶体的特异性抑制剂,目前用于治疗复发性和难治性多发性骨髓瘤。尽管其在治疗多发性骨髓瘤和其他实体瘤方面取得了成功的成功率,但它无法杀死血液中的白血病细胞。最近发现,血液中的绿叶和绿茶中存在的某些类黄酮和维生素C可通过两种化学物质之间的直接相互作用来中和硼替佐米。在这里,我们总结了为什么将硼替佐米作为化疗药物的患者应避免饮食中的类黄酮。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号